Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01816893 · ClinicalTrials.gov registry record · NA
Hypoglycemia and Autonomic Nervous System Function
A NA study, sponsored by Brigham and Women's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT01816893: Completed NA study, sponsored by Brigham and Women's Hospital.
NCT01816893 is a NA study that has completed, run by Brigham and Women's Hospital. The registered enrollment target is 22 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01816893, a NA study, has completed, sponsored by Brigham and Women's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system.
Primary Outcome
The change in baroreflex sensitivity (milliseconds/mm Hg) is calculated as baroreflex sensitivity (milliseconds/mm Hg) on day 3 \[assessed 16 hours after the clamp\] minus baroreflex sensitivity (milliseconds/mm Hg) on day 1 \[baseline assessment on the day prior to the clamp\]). Change in baroreflex sensitivity in euglycemic clamp arm is compared to change in baroreflex sensitivity in hypoglycemic arm.
Interventions
- OTHER Hypoglycemic hyperinsulinemic clamp
- OTHER Euglycemic hyperinsulinemic clamp
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2004-06-08 |
| Est. Completion | 2007-11-06 |
| Phase | NA |
What the finished NCT01816893 record still lists
NCT01816893 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 22 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 2 interventions - of which Hypoglycemic hyperinsulinemic clamp is the first listed.
NCT01816893 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01816893 about?
NCT01816893 is a clinical study titled "Hypoglycemia and Autonomic Nervous System Function". The goals of this proposal are to determine the effects of hypoglycemia on the autonomic nervous system.
What is the current status of trial NCT01816893?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2004-06-08. Estimated completion is 2007-11-06.
What interventions are being tested in trial NCT01816893?
The interventions under investigation include: Hypoglycemic hyperinsulinemic clamp (OTHER), Euglycemic hyperinsulinemic clamp (OTHER).
Who is sponsoring clinical trial NCT01816893?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01816893's enrollment target sits among peer trials
22 1756th of 2000 higher than 239 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02508038 · 22 participants · Phase 1
Alpha/Beta CD19+ Depleted Haploidentical Transplantation + Zometa for Pediatric Hematologic Malignancies and Solid Tumors
- NCT03099356 · 22 participants · Phase 2
Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
- NCT03676647 · 22 participants
Diagnostic DNA Methylation Signature in Diagnosing Thyroid Cancer After Fine-Needle Aspiration in Patients With Thyroid Nodules
- NCT04569591 · 22 participants · NA
DDAVP for Pituitary Adenoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI